Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit

JAMA Internal Medicine

Volumn 174, Issue 4, 2014, Pages 564-574

  MacLaren, Robert ^a   Reynolds, Paul M ^a   Allen, Richard R ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b Peak Statistical Services   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESOMEPRAZOLE; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; CLOSTRIDIUM DIFFICILE INFECTION; CRITICALLY ILL PATIENT; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMAN; ICD-9; INFECTION COMPLICATION; INFECTIOUS COMPLICATION; INTENSIVE CARE UNIT; INTUBATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PNEUMONIA; PRIORITY JOURNAL; PROPENSITY SCORE; RISK FACTOR; VERY ELDERLY;

ADULT; CLOSTRIDIUM INFECTIONS; COLORADO; CRITICAL ILLNESS; FEMALE; GASTROINTESTINAL HEMORRHAGE; HISTAMINE H2 ANTAGONISTS; HUMANS; INTENSIVE CARE UNITS; MALE; PHARMACOEPIDEMIOLOGY; PNEUMONIA; PROPENSITY SCORE; PROTON PUMP INHIBITORS; RESPIRATION, ARTIFICIAL; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84898413831     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2013.14673     Document Type: Article

References (38)

1. MacLaren R. A review of stress ulcer prophylaxis. J Pharm Pract. 2002;15(2):147-157.
2. Ali T, Harty RF. Stress-induced ulcer bleeding in critically ill patients. Gastroenterol Clin North Am. 2009;38(2):245-265.
3. ASHP Commission on Therapeutics. ASHP therapeutics guidelines on stress ulcer prophylaxis. Am J Health Syst Pharm. 1999;56:347-379.
4. Cook DJ, Griffith LE, Walter SD, et al; Canadian Critical Care Trials Group. The attributable mortality and length of intensive care unit stay of clinically important gastrointestinal bleeding in critically ill patients. Crit Care. 2001;5(6):368-375.
5. Wunsch H, Linde-ZwirbleWT, Angus DC, Hartman ME, Milbrandt EB, Kahn JM. The epidemiology of mechanical ventilation use in the United States. Crit Care Med. 2010;38(10): 1947-1953.
6. Cook DJ, Reeve BK, Guyatt GH, et al. Stress ulcer prophylaxis in critically ill patients: resolving discordant meta-analyses. JAMA. 1996;275(4):308-314.
7. Cook D, Guyatt G, Marshall J, et al; Canadian Critical Care Trials Group. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. N Engl J Med. 1998;338(12):791-797.
8. AlhazzaniW, Alenezi F, Jaeschke RZ, Moayyedi P, Cook DJ. Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis. Crit Care Med. 2013;41(3):693-705.
9. Lin PC, Chang CH, Hsu PI, Tseng PL, Huang YB. The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: ameta-analysis. Crit Care Med. 2010;38(4): 1197-1205.
10. Barkun AN, Bardou M, Pham CQ, MartelM. Proton pump inhibitors vs. histamine 2 receptor antagonists for stress-related mucosal bleeding prophylaxis in critically ill patients: ameta-analysis. Am J Gastroenterol. 2012;107(4):507-520.
11. Laheij RJ, Sturkenboom MC, Hassing RJ, Dieleman J, Stricker BH, Jansen JB. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA. 2004;292(16): 1955-1960.
12. Gulmez SE, Holm A, Frederiksen H, Jensen TG, Pedersen C, Hallas J. Use of proton pump inhibitors and the risk of community-acquired pneumonia: a population-based case-control study. Arch Intern Med. 2007;167(9):950-955.
13. Sarkar M, Hennessy S, Yang YX. Proton-pump inhibitor use and the risk for community-acquired pneumonia. Ann Intern Med. 2008;149(6): 391-398.
14. Eom CS, Jeon CY, Lim JW, Cho EG, Park SM, Lee KS. Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis. CMAJ. 2011;183(3):310-319.
15. Herzig SJ, Howell MD, Ngo LH, Marcantonio ER. Acid-suppressive medication use and the risk for hospital-acquired pneumonia. JAMA. 2009;301(20):2120-2128.
16. Kwok CS, Arthur AK, Anibueze CI, Singh S, Cavallazzi R, Loke YK. Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis. Am J Gastroenterol. 2012;107(7):1011-1019.
17. Howell MD, Novack V, Grgurich P, et al. Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection. Arch Intern Med. 2010;170(9):784-790.
18. Safdar N, Dezfulian C, Collard HR, Saint S. Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med. 2005;33(10):2184-2193.
19. Umscheid CA, MitchellMD, Doshi JA, Agarwal R, Williams K, Brennan PJ. Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related mortality and costs. Infect Control Hosp Epidemiol. 2011;32(2):101-114.
20. Burgmann H, Hiesmayr JM, Savey A, Bauer P, Metnitz B, Metnitz PG. Impact of nosocomial infections on clinical outcome and resource consumption in critically ill patients. Intensive Care Med. 2010;36(9):1597-1601.
21. Kollef MH, Hamilton CW, Ernst FR. Economic impact of ventilator- associated pneumonia in a large matched cohort. Infect Control Hosp Epidemiol. 2012;33(3):250-256.
22. Lipp MJ, Nero DC, Callahan MA. Impact of hospital-acquired Clostridium difficile. J Gastroenterol Hepatol. 2012;27(11):1733-1737.
23. Ghantoji SS, Sail K, Lairson DR, DuPont HL, Garey KW. Economic healthcare costs of Clostridium difficile infection: a systematic review. J Hosp Infect. 2010;74(4):309-318.
24. McGlone SM, Bailey RR, Zimmer SM, et al. The economic burden of Clostridium difficile. Clin Microbiol Infect. 2012;18(3):282-289.
25. Streiner DL, Norman GR. The pros and cons of propensity scores. Chest. 2012;142(6):1380-1382.
26. Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res. 2011;46(3):399-424.
27. Herzig SJ, Vaughn BP, Howell MD, Ngo LH, Marcantonio ER. Acid-suppressive medication use and the risk for nosocomial gastrointestinal tract bleeding. Arch Intern Med. 2011;171(11):991-997.
28. Conrad SA, Gabrielli A, Margolis B, et al. Randomized, double-blind comparison of immediate-release omeprazole oral suspensionversus intravenous cimetidine for the prevention of upper gastrointestinal bleeding in critically ill patients. Crit Care Med. 2005;33(4):760-765.
29. LevyMJ, Seelig CB, Robinson NJ, Ranney JE. Comparison of omeprazole and ranitidine for stress ulcer prophylaxis. Dig Dis Sci. 1997;42(6):1255-1259.
30. Dellinger RP, Levy MM, Rhodes A, et al; Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013;39(2):165-228.
31. Cook D, Heyland D, Griffith L, Cook R, Marshall J, Pagliarello J; Canadian Critical Care Trials Group. Risk factors for clinically important upper gastrointestinal bleeding in patients requiring mechanical ventilation. Crit Care Med. 1999;27(12):2812-2817.
32. Cook DJ, Fuller HD, Guyatt GH, et al; Canadian Critical Care Trials Group. Risk factors for gastrointestinal bleeding in critically ill patients. N Engl J Med. 1994;330(6):377-381.
33. Brown RB, Klar J, Teres D, Lemeshow S, Sands M. Prospective study of clinical bleeding in intensive care unit patients. Crit Care Med. 1988;16(12):1171-1176.
34. Cochard JF, Leger A, Pinaquy C, et al. Gastrointestinal bleeding in trauma patients: incidence and risk factors [abstract]. Intensive Care Med. 1997;23:S140.
35. Schuster DP, Rowley H, Feinstein S,McGue MK, Zuckerman GR. Prospective evaluation of the risk of upper gastrointestinal bleeding after admission to a medical intensive care unit. Am J Med. 1984;76(4):623-630.
36. Huang J, Cao Y, Liao C,Wu L, Gao F. Effect of histamine-2-receptor antagonists versus sucralfate on stress ulcer prophylaxis in mechanically ventilated patients: ameta-analysis of 10 randomized controlled trials. Crit Care. 2010;14(5):R194.
37. Messori A, Trippoli S, Vaiani M, GoriniM, Corrado A. Bleeding and pneumonia in intensive care patients given ranitidine and sucralfate for prevention of stress ulcer:meta-analysis of randomised controlled trials. BMJ. 2000;321(7269):1103-1106.
38. JhungMA, Banerjee SN. Administrative coding data and health care-associated infections. Clin Infect Dis. 2009;49(6):949-955